Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Guangzhou-Israel Biomed Fund to Raise $300 Million

publication date: Jun 1, 2021

The Guangzhou government is raising $300 million from Guangzhou institutions for the Guangzhou Sino-Israel Biotech Investment Fund’s (GIBF) second fund. Shuki Gleitman, the former chief scientist of the Israel Ministry of Industry and Trade, is a partner with Guangzhou. The first fund raised $100 million for Israeli medical device companies. The fund helped its portfolio companies to found China subsidiaries, which carried out clinical trials in China. In the new fund, GIBF will invest $15-$20 million in each biomedical company. More details.....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital